Clinical utility of antihuman lambda chain‐based enzyme‐linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti‐infliximab antibodies
暂无分享,去创建一个
R. Eliakim | U. Kopylov | Y. Mazor | S. Ben-Horin | L. Katz | Y. Chowers | M. Yavzori | O. Picard | E. Fudim | D. Coscas